FibroGen Reports Q3 Earnings Beat on Revenue and EPS
FibroGen has reported its third-quarter financial results, exceeding analyst expectations for both earnings per share (EPS) and revenue. The company posted a GAAP EPS of $0.04, significantly outperforming the anticipated deficit. Revenue for the quarter reached $1.76 million, representing a 60% increase year-over-year. This figure also surpassed market estimates by $0.04 million, signaling strong top-line growth compared to the previous year.

Tickers: $FGEN
Topics: earnings beat GAAP EPS revenue growth